4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-23-067360
SVP and General Counsel sold 7,000 shares at an average $201.50 ($1,410,480)
- SVP and General Counsel acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Brian Joseph SVP and General Counsel | 2023-11-29 | Option exercise | +4,000 | $73.75 | $295,000 | 19,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-29 | Sale | −1,000 | $198.40 | $198,400 | 18,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-29 | Sale | −3,000 | $199.45 | $598,350 | 15,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-30 | Option exercise | +3,000 | $73.75 | $221,250 | 18,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-30 | Sale | −1,000 | $204.00 | $204,000 | 17,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-30 | Sale | −1,000 | $203.00 | $203,000 | 16,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-11-30 | Sale | −1,000 | $206.73 | $206,730 | 15,001 | D |
| Derivatives | |||||||
| Lynch Brian Joseph SVP and General Counsel | 2023-11-29 | Option exercise · Stock Option (Right to Buy) | −4,000 | 21,000 | D | ||
| Lynch Brian Joseph SVP and General Counsel | 2023-11-30 | Option exercise · Stock Option (Right to Buy) | −3,000 | 18,000 | D | ||
| Open-market sales · 7,000 sh · avg $201.50 · $1,410,480 | |||||||
Loading xslF345X05/ownership.xml…